Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription factor binding	MAGEA2 MAGEA3 MAGEA6 MAGEA11 MAGEA12 TCF3 FLYWCH1 NSD1 BTAF1 TRIM68 GRM1 PRAMEF1 JUP PRAMEF14	1.81e-05	753	98	14	GO:0008134
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	MAGEA2 MAGEA3 MAGEA6 MAGEA11 MAGEA12 TCF3 NSD1 TRIM68 GRM1 PRAMEF1 JUP PRAMEF14	2.78e-05	582	98	12	GO:0140297
GeneOntologyMolecularFunction	diphosphoinositol tetrakisphosphate kinase activity	IP6K3 IP6K2	7.13e-05	3	98	2	GO:0052839
GeneOntologyMolecularFunction	inositol 5-diphosphate pentakisphosphate 5-kinase activity	IP6K3 IP6K2	7.13e-05	3	98	2	GO:0052836
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR3	1.42e-04	4	98	2	GO:0005219
GeneOntologyMolecularFunction	diphosphoinositol pentakisphosphate kinase activity	IP6K3 IP6K2	2.36e-04	5	98	2	GO:0000829
GeneOntologyMolecularFunction	inositol hexakisphosphate kinase activity	IP6K3 IP6K2	2.36e-04	5	98	2	GO:0000828
GeneOntologyMolecularFunction	inositol-1,3,4,5,6-pentakisphosphate kinase activity	IP6K3 IP6K2	2.36e-04	5	98	2	GO:0000827
GeneOntologyMolecularFunction	cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication	DSP JUP	2.36e-04	5	98	2	GO:0086083
GeneOntologyMolecularFunction	inositol hexakisphosphate 5-kinase activity	IP6K3 IP6K2	2.36e-04	5	98	2	GO:0000832
GeneOntologyMolecularFunction	nuclear receptor binding	NSD1 TRIM68 GRM1 PRAMEF1 JUP PRAMEF14	3.21e-04	187	98	6	GO:0016922
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR1 RYR3	3.53e-04	6	98	2	GO:0048763
GeneOntologyMolecularFunction	zinc ion binding	TRIM49 ENPP7 TRIM49C NSD1 TRIM49D1 TRIM43 TRIM68 TRIM43B PRKCA DMD TRIM49B ZNF282 TRIM51G	4.09e-04	891	98	13	GO:0008270
GeneOntologyMolecularFunction	ubiquitin protein ligase activity	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 TRIM43B TRIM49B TRIM51G	4.93e-04	372	98	8	GO:0061630
GeneOntologyMolecularFunction	ubiquitin-like protein ligase activity	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 TRIM43B TRIM49B TRIM51G	7.66e-04	398	98	8	GO:0061659
GeneOntologyMolecularFunction	histone deacetylase binding	MAGEA2 MAGEA3 MAGEA6 MAGEA11 MAGEA12	7.92e-04	147	98	5	GO:0042826
GeneOntologyMolecularFunction	phosphotransferase activity, phosphate group as acceptor	IP6K3 PALS1 IP6K2	1.07e-03	41	98	3	GO:0016776
GeneOntologyMolecularFunction	protein kinase binding	TRIM49 TCF3 DSP TRIM49C TRIM43 CNKSR2 TRIM68 TRIM43B JUP PLCB4 SMCR8 TRIM49B	1.16e-03	873	98	12	GO:0019901
GeneOntologyMolecularFunction	inositol phosphate kinase activity	IP6K3 IP6K2	1.27e-03	11	98	2	GO:0180030
GeneOntologyMolecularFunction	ubiquitin-like protein ligase binding	MAGEA2 MAGEA3 MAGEA6 MAGEA11 MAGEA12 STAM NDUFS2	1.92e-03	358	98	7	GO:0044389
GeneOntologyMolecularFunction	ubiquitin-protein transferase activity	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 TRIM43B TRIM49B TRIM51G	2.29e-03	473	98	8	GO:0004842
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	NSD1 PRAMEF1 PRAMEF14	2.50e-03	55	98	3	GO:0042974
GeneOntologyMolecularFunction	lipid transfer activity	ABCA1 ATG2B STAR	2.77e-03	57	98	3	GO:0120013
GeneOntologyMolecularFunction	kinase binding	TRIM49 TCF3 DSP TRIM49C TRIM43 CNKSR2 TRIM68 TRIM43B JUP PLCB4 SMCR8 TRIM49B	2.77e-03	969	98	12	GO:0019900
GeneOntologyBiologicalProcess	desmosome organization	DSP JUP PRKCA	1.22e-05	10	98	3	GO:0002934
Domain	SPRY	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 RYR1 RYR3 SPRYD7 TRIM43B TRIM49B	2.30e-11	87	96	10	SM00449
Domain	SPRY	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 RYR1 RYR3 SPRYD7 TRIM43B TRIM49B	5.05e-11	94	96	10	PF00622
Domain	SPRY_dom	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 RYR1 RYR3 SPRYD7 TRIM43B TRIM49B	5.05e-11	94	96	10	IPR003877
Domain	B30.2/SPRY	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 RYR1 RYR3 SPRYD7 TRIM43B TRIM49B	5.62e-11	95	96	10	IPR001870
Domain	B302_SPRY	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 RYR1 RYR3 SPRYD7 TRIM43B TRIM49B	5.62e-11	95	96	10	PS50188
Domain	BBOX	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 TRIM43B TRIM49B	6.32e-08	69	96	7	SM00336
Domain	Butyrophylin	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 TRIM43B TRIM49B	6.99e-08	70	96	7	IPR003879
Domain	-	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 TRIM43B TRIM49B	7.72e-08	71	96	7	4.10.45.10
Domain	ZF_BBOX	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 TRIM43B TRIM49B	1.78e-07	80	96	7	PS50119
Domain	ConA-like_dom	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 RYR1 RYR3 SPRYD7 TRIM43B TRIM49B	1.87e-07	219	96	10	IPR013320
Domain	Znf_B-box	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 TRIM43B TRIM49B	1.94e-07	81	96	7	IPR000315
Domain	zf-B_box	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 TRIM49B	1.87e-06	72	96	6	PF00643
Domain	MAGE_N	MAGEA3 MAGEA6 MAGEA11 MAGEA12	2.98e-06	20	96	4	SM01392
Domain	MAGE_N	MAGEA3 MAGEA6 MAGEA11 MAGEA12	4.47e-06	22	96	4	PF12440
Domain	MAGE_N	MAGEA3 MAGEA6 MAGEA11 MAGEA12	4.47e-06	22	96	4	IPR021072
Domain	MAGEA3/MAGEA6	MAGEA3 MAGEA6	2.61e-05	2	96	2	IPR030097
Domain	MAGE	MAGEA3 MAGEA6 MAGEA11 MAGEA12	2.70e-05	34	96	4	SM01373
Domain	RING	TRIM49 TRIM49C NSD1 TRIM49D1 TRIM43 TRIM68 TRIM43B KMT2D TRIM49B	2.74e-05	305	96	9	SM00184
Domain	MAGE	MAGEA3 MAGEA6 MAGEA11 MAGEA12	3.40e-05	36	96	4	PS50838
Domain	MAGE	MAGEA3 MAGEA6 MAGEA11 MAGEA12	3.40e-05	36	96	4	PF01454
Domain	MHD_dom	MAGEA3 MAGEA6 MAGEA11 MAGEA12	3.40e-05	36	96	4	IPR002190
Domain	Znf_RING	TRIM49 TRIM49C NSD1 TRIM49D1 TRIM43 TRIM68 TRIM43B KMT2D TRIM49B	4.61e-05	326	96	9	IPR001841
Domain	Ryanrecept_TM4-6	RYR1 RYR3	7.82e-05	3	96	2	IPR009460
Domain	-	RASA4 RASA4B	7.82e-05	3	96	2	4.10.1130.10
Domain	RyR	RYR1 RYR3	7.82e-05	3	96	2	PF02026
Domain	Ryanodine_rcpt	RYR1 RYR3	7.82e-05	3	96	2	IPR003032
Domain	RR_TM4-6	RYR1 RYR3	7.82e-05	3	96	2	PF06459
Domain	Ryan_recept	RYR1 RYR3	7.82e-05	3	96	2	IPR013333
Domain	-	TRIM49 TRIM49C NSD1 TRIM49D1 TRIM43 TRIM68 TRIM43B KMT2D PHF3 TRIM49B	1.04e-04	449	96	10	3.30.40.10
Domain	Znf_RING/FYVE/PHD	TRIM49 TRIM49C NSD1 TRIM49D1 TRIM43 TRIM68 TRIM43B KMT2D PHF3 TRIM49B	1.25e-04	459	96	10	IPR013083
Domain	ZF_RING_2	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 TRIM43B KMT2D TRIM49B	1.50e-04	298	96	8	PS50089
Domain	RIH_assoc	RYR1 RYR3	3.87e-04	6	96	2	PF08454
Domain	RIH_assoc-dom	RYR1 RYR3	3.87e-04	6	96	2	IPR013662
Domain	RIH_dom	RYR1 RYR3	3.87e-04	6	96	2	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR3	3.87e-04	6	96	2	IPR014821
Domain	Ryanodine_recept-rel	RYR1 RYR3	3.87e-04	6	96	2	IPR015925
Domain	-	RYR1 RYR3	3.87e-04	6	96	2	1.25.10.30
Domain	RYDR_ITPR	RYR1 RYR3	3.87e-04	6	96	2	PF01365
Domain	Ins145_P3_rec	RYR1 RYR3	3.87e-04	6	96	2	PF08709
Domain	IPK	IP6K3 IP6K2	5.40e-04	7	96	2	PF03770
Domain	IPK	IP6K3 IP6K2	5.40e-04	7	96	2	IPR005522
Domain	C2	MYOF RASA4 PRKCA RASA4B PLCB4	5.77e-04	131	96	5	PF00168
Domain	C2	MYOF RASA4 PRKCA RASA4B PLCB4	7.07e-04	137	96	5	SM00239
Domain	ZF_RING_1	TRIM49 TRIM49C TRIM43 TRIM68 TRIM43B KMT2D TRIM49B	7.58e-04	291	96	7	PS00518
Domain	C2	MYOF RASA4 PRKCA RASA4B PLCB4	8.31e-04	142	96	5	PS50004
Domain	BTK	RASA4 RASA4B	9.19e-04	9	96	2	SM00107
Domain	Znf_Btk_motif	RASA4 RASA4B	9.19e-04	9	96	2	IPR001562
Domain	BTK	RASA4 RASA4B	9.19e-04	9	96	2	PF00779
Domain	ZF_BTK	RASA4 RASA4B	9.19e-04	9	96	2	PS51113
Domain	-	MYOF RASA4 PRKCA RASA4B PLCB4	1.00e-03	148	96	5	2.60.40.150
Domain	MIR	RYR1 RYR3	1.15e-03	10	96	2	PS50919
Domain	MIR	RYR1 RYR3	1.15e-03	10	96	2	PF02815
Domain	MIR	RYR1 RYR3	1.15e-03	10	96	2	SM00472
Domain	MIR_motif	RYR1 RYR3	1.15e-03	10	96	2	IPR016093
Domain	EMI	EMILIN2 EGFL8	1.15e-03	10	96	2	PF07546
Domain	C2_dom	MYOF RASA4 PRKCA RASA4B PLCB4	1.58e-03	164	96	5	IPR000008
Domain	RasGAP	RASA4 RASA4B	2.29e-03	14	96	2	SM00323
Domain	RasGAP_CS	RASA4 RASA4B	2.29e-03	14	96	2	IPR023152
Domain	RasGAP	RASA4 RASA4B	2.63e-03	15	96	2	PF00616
Domain	RAS_GTPASE_ACTIV_1	RASA4 RASA4B	2.63e-03	15	96	2	PS00509
Domain	RAS_GTPASE_ACTIV_2	RASA4 RASA4B	2.63e-03	15	96	2	PS50018
Domain	Post-SET_dom	NSD1 KMT2D	2.99e-03	16	96	2	IPR003616
Domain	EMI_domain	EMILIN2 EGFL8	2.99e-03	16	96	2	IPR011489
Domain	PostSET	NSD1 KMT2D	2.99e-03	16	96	2	SM00508
Domain	-	RASA4 RASA4B	2.99e-03	16	96	2	1.10.506.10
Domain	POST_SET	NSD1 KMT2D	2.99e-03	16	96	2	PS50868
Domain	PH	CNKSR2 FARP2 ARHGEF40 RASA4 RASA4B ARHGEF6	3.12e-03	278	96	6	SM00233
Domain	PH_DOMAIN	CNKSR2 FARP2 ARHGEF40 RASA4 RASA4B ARHGEF6	3.18e-03	279	96	6	PS50003
Domain	PH_domain	CNKSR2 FARP2 ARHGEF40 RASA4 RASA4B ARHGEF6	3.23e-03	280	96	6	IPR001849
Domain	EMI	EMILIN2 EGFL8	3.38e-03	17	96	2	PS51041
Domain	RasGAP_dom	RASA4 RASA4B	3.79e-03	18	96	2	IPR001936
Domain	-	CNKSR2 FARP2 ARHGEF40 RASA4 RASA4B PLCB4 ARHGEF6	4.04e-03	391	96	7	2.30.29.30
Domain	DH_1	FARP2 ARHGEF40 ARHGEF6	4.18e-03	63	96	3	PS00741
Pathway	KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY	GRM1 PRKCA PLCB4	2.59e-05	13	65	3	M47656
Pathway	WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA	GRM1 RYR3 PLCB4	1.35e-04	22	65	3	M39795
Pathway	WP_WNT_SIGNALING_PATHWAY	TCF3 JUP CSNK1A1L CSNK1A1 PRKCA	1.50e-04	110	65	5	MM15977
Pathway	KEGG_CALCIUM_SIGNALING_PATHWAY	GRM1 RYR1 RYR3 PRKCA CACNA1H PLCB4	1.66e-04	178	65	6	M2890
Pathway	WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA	TCF3 JUP CSNK1A1	2.26e-04	26	65	3	M39407
Pubmed	The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28.	MAGEA2 MAGEA3 MAGEA6 MAGEA11 MAGEA12	3.85e-10	14	102	5	8575766
Pubmed	Trim43a, Trim43b, and Trim43c: Novel mouse genes expressed specifically in mouse preimplantation embryos.	TRIM49 TRIM49C TRIM43 TRIM43B TRIM49B	5.76e-10	15	102	5	19703589
Pubmed	Structure, chromosomal localization, and expression of 12 genes of the MAGE family.	MAGEA2 MAGEA3 MAGEA6 MAGEA11 MAGEA12	5.76e-10	15	102	5	7927540
Pubmed	Identification of a genomic reservoir for new TRIM genes in primate genomes.	TRIM49 TRIM49C TRIM49D1 TRIM49B TRIM51G	2.21e-09	19	102	5	22144910
Pubmed	Expression of melanoma-associated antigens in oral squamous cell carcinoma.	MAGEA2 MAGEA3 MAGEA6 MAGEA12	2.42e-09	7	102	4	18197853
Pubmed	MAGE cancer-testis antigens protect the mammalian germline under environmental stress.	MAGEA3 MAGEA6 MAGEA11 MAGEA12	4.84e-09	8	102	4	31149633
Pubmed	The Magea gene cluster regulates male germ cell apoptosis without affecting the fertility in mice.	MAGEA3 MAGEA6 MAGEA11 MAGEA12	4.84e-09	8	102	4	27226137
Pubmed	A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.	DRD2 RYR1 RYR3	9.78e-08	4	102	3	18206662
Pubmed	Cloning and analysis of MAGE-1-related genes.	MAGEA3 MAGEA6 MAGEA12	2.44e-07	5	102	3	8037761
Pubmed	Lineage-specific biology revealed by a finished genome assembly of the mouse.	TRIM49 TRIM49C TRIM43 TRIM43B TRIM49B	6.09e-07	55	102	5	19468303
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	DSP ATG2B SMC4 NSD1 PALS1 JUP FASN KMT2D CCT5 PHF3 WIPI2	6.70e-07	549	102	11	38280479
Pubmed	MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patients with lung cancer and non-malignant lung diseases.	MAGEA2 MAGEA3 MAGEA6	8.50e-07	7	102	3	22134685
Pubmed	Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.	MAGEA2 MAGEA3 MAGEA12	8.50e-07	7	102	3	17634428
Pubmed	Expression dynamics of Mage family genes during self-renewal and differentiation of mouse pluripotent stem and teratocarcinoma cells.	MAGEA3 MAGEA6 MAGEA11 MAGEA12	2.67e-06	33	102	4	31143371
Pubmed	The differential regulation of steroidogenic acute regulatory protein-mediated steroidogenesis by type I and type II PKA in MA-10 cells.	STAR PRKCA	8.52e-06	2	102	2	19111595
Pubmed	The thalamic mGluR1-PLCβ4 pathway is critical in sleep architecture.	GRM1 PLCB4	8.52e-06	2	102	2	27998287
Pubmed	Systems biology approach identifies the kinase Csnk1a1 as a regulator of the DNA damage response in embryonic stem cells.	CSNK1A1L CSNK1A1	8.52e-06	2	102	2	23354688
Pubmed	Role of thalamic phospholipase C[beta]4 mediated by metabotropic glutamate receptor type 1 in inflammatory pain.	GRM1 PLCB4	8.52e-06	2	102	2	12954872
Pubmed	miR-1273g silences MAGEA3/6 to inhibit human colorectal cancer cell growth via activation of AMPK signaling.	MAGEA3 MAGEA6	8.52e-06	2	102	2	30056111
Pubmed	CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway.	RASA4 RASA4B	8.52e-06	2	102	2	11448776
Pubmed	Phospholipase C-beta4 is essential for the progression of the normal sleep sequence and ultradian body temperature rhythms in mice.	GRM1 PLCB4	8.52e-06	2	102	2	19898623
Pubmed	Tissue-specific distribution of mouse casein kinase I alpha mRNA.	CSNK1A1L CSNK1A1	8.52e-06	2	102	2	9522121
Pubmed	Contractile impairment and structural alterations of skeletal muscles from knockout mice lacking type 1 and type 3 ryanodine receptors.	RYR1 RYR3	8.52e-06	2	102	2	9489997
Pubmed	CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling.	CSNK1A1L CSNK1A1	8.52e-06	2	102	2	37723657
Pubmed	Casein Kinase 1α Regulates Testosterone Synthesis and Testis Development in Adult Mice.	CSNK1A1L CSNK1A1	8.52e-06	2	102	2	36929849
Pubmed	The block of ryanodine receptors selectively inhibits fetal myoblast differentiation.	RYR1 RYR3	8.52e-06	2	102	2	12640042
Pubmed	Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum.	GRM1 PLCB4	8.52e-06	2	102	2	16033892
Pubmed	Possible involvement of ryanodine receptor-mediated intracellular calcium release in the effect of corticotropin-releasing factor on adrenocorticotropin secretion.	RYR1 RYR3	8.52e-06	2	102	2	14592949
Pubmed	Macrophage mitochondrial damage from StAR transport of 7-hydroperoxycholesterol: implications for oxidative stress-impaired reverse cholesterol transport.	ABCA1 STAR	8.52e-06	2	102	2	24269887
Pubmed	Class III β-Tubulin Expression Is of Value in Selecting nab -Paclitaxel and Gemcitabine as First-Line Therapy in Unresectable Pancreatic Cancer.	CSNK1A1L CSNK1A1	8.52e-06	2	102	2	35695793
Pubmed	Alien/CSN2 gene expression is regulated by thyroid hormone in rat brain.	VWF COPS2	8.52e-06	2	102	2	12606288
Pubmed	Exploring the role of casein kinase 1α splice variants across cancer cell lines.	CSNK1A1L CSNK1A1	8.52e-06	2	102	2	38852281
Pubmed	Morphological abnormalities of adrenal gland and hypertrophy of liver in mutant mice lacking ryanodine receptors.	RYR1 RYR3	8.52e-06	2	102	2	9799464
Pubmed	Casein kinase 1 alpha regulates chromosome congression and separation during mouse oocyte meiotic maturation and early embryo development.	CSNK1A1L CSNK1A1	8.52e-06	2	102	2	23690993
Pubmed	Opposing effects of protein kinase C and protein kinase A on metabotropic glutamate receptor signaling: selective desensitization of the inositol trisphosphate/Ca2+ pathway by phosphorylation of the receptor-G protein-coupling domain.	GRM1 PRKCA	8.52e-06	2	102	2	10823959
Pubmed	Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer.	MAGEA6 MAGEA11	8.52e-06	2	102	2	35022469
Pubmed	Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice.	CSNK1A1L CSNK1A1	8.52e-06	2	102	2	36542875
Pubmed	Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development.	RYR1 RYR3	8.52e-06	2	102	2	17118445
Pubmed	RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle.	RYR1 RYR3	8.52e-06	2	102	2	11500519
Pubmed	Functional interaction between co-expressed MAGE-A proteins.	MAGEA6 MAGEA11	8.52e-06	2	102	2	28542476
Pubmed	Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene.	RYR1 RYR3	8.52e-06	2	102	2	12565913
Pubmed	Drosophila glucome screening identifies Ck1alpha as a regulator of mammalian glucose metabolism.	CSNK1A1L CSNK1A1	8.52e-06	2	102	2	25994086
Pubmed	Senolytics prevent caveolar CaV 3.2-RyR axis malfunction in old vascular smooth muscle.	RYR1 CACNA1H	8.52e-06	2	102	2	37837625
Pubmed	Functional and morphological features of skeletal muscle from mutant mice lacking both type 1 and type 3 ryanodine receptors.	RYR1 RYR3	8.52e-06	2	102	2	9192302
Pubmed	The amino-terminal domain of desmoplakin binds to plakoglobin and clusters desmosomal cadherin-plakoglobin complexes.	DSP JUP	8.52e-06	2	102	2	9348293
Pubmed	Isolation and partial cloning of ryanodine-sensitive Ca2+ release channel protein isoforms from human myometrial smooth muscle.	RYR1 RYR3	8.52e-06	2	102	2	7556644
Pubmed	Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay.	MAGEA6 MAGEA12	8.52e-06	2	102	2	22707303
Pubmed	Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction.	RYR1 RYR3	8.52e-06	2	102	2	15894801
Pubmed	Effect of calmodulin on Ca2+-induced Ca2+ release of skeletal muscle from mutant mice expressing either ryanodine receptor type 1 or type 3.	RYR1 RYR3	8.52e-06	2	102	2	9817784
Pubmed	Csnk1a1 inhibition modulates the inflammatory secretome and enhances response to radiotherapy in glioma.	CSNK1A1L CSNK1A1	8.52e-06	2	102	2	34216174
Pubmed	An essential function for the calcium-promoted Ras inactivator in Fcgamma receptor-mediated phagocytosis.	RASA4 RASA4B	8.52e-06	2	102	2	16041389
Pubmed	Casein Kinase 1α as a Novel Factor Affects Thyrotropin Synthesis via PKC/ERK/CREB Signaling.	CSNK1A1L CSNK1A1	8.52e-06	2	102	2	37108197
Pubmed	A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence.	MAGEA3 MAGEA6	8.52e-06	2	102	2	25564441
Pubmed	Premature Termination Codon in 5' Region of Desmoplakin and Plakoglobin Genes May Escape Nonsense-Mediated Decay through the Reinitiation of Translation.	DSP JUP	8.52e-06	2	102	2	35054841
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	VWF DSP CNKSR2 RYR1 MYOF PALS1 JUP FASN CD14 CCT5 VPS35 PRKCA ATP6V0D2	8.86e-06	1016	102	13	19056867
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	DSP ATG2B SMC4 MYOF JUP FASN MYPN	1.10e-05	256	102	7	33397691
Pubmed	The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15.	COPS2 CSNK1A1L CSNK1A1	1.33e-05	16	102	3	19576224
Pubmed	An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells.	DSP SMC4 OAT MYOF JUP FASN CCT5 VPS35	2.31e-05	397	102	8	21319273
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR3	2.55e-05	3	102	2	18403125
Pubmed	Characterization and mapping of the 12 kDa FK506-binding protein (FKBP12)-binding site on different isoforms of the ryanodine receptor and of the inositol 1,4,5-trisphosphate receptor.	RYR1 RYR3	2.55e-05	3	102	2	11171121
Pubmed	Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.	PRKCA CACNA1H	2.55e-05	3	102	2	26170457
Pubmed	VE-cadherin and desmoplakin are assembled into dermal microvascular endothelial intercellular junctions: a pivotal role for plakoglobin in the recruitment of desmoplakin to intercellular junctions.	DSP JUP	2.55e-05	3	102	2	9739078
Pubmed	CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane.	RASA4 RASA4B	2.55e-05	3	102	2	25637021
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR1 RYR3	2.55e-05	3	102	2	7876312
Pubmed	Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia.	CSNK1A1L CSNK1A1	2.55e-05	3	102	2	24616378
Pubmed	The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy.	DSP JUP	2.55e-05	3	102	2	24276085
Pubmed	Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.	RYR1 RYR3	2.55e-05	3	102	2	22948152
Pubmed	Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.	CSNK1A1L CSNK1A1	2.55e-05	3	102	2	25242043
Pubmed	Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.	RYR1 RYR3	2.55e-05	3	102	2	10788707
Pubmed	Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors.	CSNK1A1L CSNK1A1	2.55e-05	3	102	2	28655862
Pubmed	Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.	RYR1 RYR3	2.55e-05	3	102	2	7621815
Pubmed	Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradation.	ABCA1 COPS2	2.55e-05	3	102	2	27017521
Pubmed	Molecular identification of the ryanodine receptor pore-forming segment.	RYR1 RYR3	2.55e-05	3	102	2	10473538
Pubmed	The calcium ATPase SERCA2 regulates desmoplakin dynamics and intercellular adhesive strength through modulation of PKCα signaling.	DSP PRKCA	2.55e-05	3	102	2	21156808
Pubmed	Expression of MAGE genes in primary and metastatic cutaneous melanoma.	MAGEA2 MAGEA3	2.55e-05	3	102	2	7591235
Pubmed	Differential alterations in expressions of ryanodine receptor subtypes in cerebellar cortical neurons of an ataxic mutant, rolling mouse Nagoya.	RYR1 RYR3	2.55e-05	3	102	2	18313230
Pubmed	CK1α ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation.	CSNK1A1L CSNK1A1	2.55e-05	3	102	2	28878021
Pubmed	Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.	DSP JUP	2.55e-05	3	102	2	16823493
Pubmed	CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex.	CD14 TLR1	2.55e-05	3	102	2	16848791
Pubmed	Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.	RYR1 RYR3	2.55e-05	3	102	2	18434746
Pubmed	Type I Interferons Control Proliferation and Function of the Intestinal Epithelium.	CSNK1A1L CSNK1A1	2.55e-05	3	102	2	26811327
Pubmed	Lysine methyltransferase 2D regulates muscle fiber size and muscle cell differentiation.	KMT2D DMD	2.55e-05	3	102	2	34613626
Pubmed	Identification and characterization of a novel inositol hexakisphosphate kinase.	IP6K3 IP6K2	2.55e-05	3	102	2	11502751
Pubmed	SPRY domains in ryanodine receptors (Ca(2+)-release channels).	RYR1 RYR3	2.55e-05	3	102	2	9204703
Pubmed	Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling.	CSNK1A1L CSNK1A1	2.55e-05	3	102	2	19805514
Pubmed	Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.	RYR1 RYR3	2.55e-05	3	102	2	21881589
Pubmed	Plakoglobin is required for effective intermediate filament anchorage to desmosomes.	DSP JUP	2.55e-05	3	102	2	18496566
Pubmed	Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).	RYR1 RYR3	2.55e-05	3	102	2	12213830
Pubmed	Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.	RYR1 RYR3	2.55e-05	3	102	2	9242641
Pubmed	The COP9 signalosome controls ubiquitinylation of ABCA1.	ABCA1 COPS2	2.55e-05	3	102	2	19268428
Pubmed	Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly.	ABCA1 PRKCA	2.55e-05	3	102	2	12952980
Pubmed	Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.	RYR1 RYR3	2.55e-05	3	102	2	25239916
Pubmed	Plakophilin 2: a critical scaffold for PKC alpha that regulates intercellular junction assembly.	DSP PRKCA	2.55e-05	3	102	2	18474624
Pubmed	Disease mutations in desmoplakin inhibit Cx43 membrane targeting mediated by desmoplakin-EB1 interactions.	DSP JUP	2.55e-05	3	102	2	25225338
Pubmed	A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.	RYR1 RYR3	2.55e-05	3	102	2	18643873
Pubmed	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	RYR1 RYR3	2.55e-05	3	102	2	11159936
Pubmed	P/Q-type and T-type calcium channels, but not type 3 transient receptor potential cation channels, are involved in inhibition of dendritic growth after chronic metabotropic glutamate receptor type 1 and protein kinase C activation in cerebellar Purkinje cells.	GRM1 PRKCA	2.55e-05	3	102	2	22188405
Pubmed	Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.	RYR1 RYR3	2.55e-05	3	102	2	7959768
Pubmed	The organization of proteins in the human red blood cell membrane. A review.	RYR1 RYR3	2.55e-05	3	102	2	4600883
Pubmed	Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs.	RYR1 RYR3	2.55e-05	3	102	2	7635066
Interaction	SKP2 interactions	TRIM49 MAGEA11 TCF3 DRD2 ATG2B CCNO COPS2 PKMYT1 CD14	1.10e-05	296	95	9	int:SKP2
Interaction	DCAF12 interactions	MAGEA3 DSP JUP CCT5 LUC7L2 VPS35	1.22e-05	108	95	6	int:DCAF12
Cytoband	Xq28	MAGEA2 MAGEA3 HAUS7 MAGEA6 MAGEA11 MAGEA12	2.89e-06	176	102	6	Xq28
Cytoband	Ensembl 112 genes in cytogenetic band chrXq28	MAGEA2 MAGEA3 HAUS7 MAGEA6 MAGEA11 MAGEA12	8.64e-06	213	102	6	chrXq28
GeneFamily	Ring finger proteins\|Tripartite motif containing\|ARF GTPase family	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 TRIM43B TRIM49B TRIM51G	6.06e-09	95	76	8	59
GeneFamily	MAGE family	MAGEA2 MAGEA3 MAGEA6 MAGEA11 MAGEA12	6.74e-07	40	76	5	1136
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR3	5.22e-05	3	76	2	287
GeneFamily	Ring finger proteins	TRIM49 TRIM49C TRIM49D1 TRIM43 TRIM68 TRIM43B TRIM49B	1.56e-04	275	76	7	58
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	RASA4 RASA4B	7.68e-04	10	76	2	830
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	FARP2 ARHGEF40 ARHGEF6	2.70e-03	66	76	3	722
GeneFamily	PRAME family	PRAMEF1 PRAMEF14	4.53e-03	24	76	2	686
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	B3GNT5 EMILIN2 RYR1 CD14 DNAJA4 TLR1 ATP6V0D2	2.72e-07	189	102	7	b8cbfc47f3f40b6fccd15899d58c87d07b0001aa
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DSP FAM111B PKMYT1 MYOF JUP IGFBP3	6.20e-06	197	102	6	2430f31d9312338e0ca23bfc6bdb0365340860fd
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA1 B3GNT5 EMILIN2 RYR1 CD14 TLR1	6.38e-06	198	102	6	c7dbf24caae5c4ef285845d13055de9e07281bb3
ToppCell	Sigmoid-Dendritic_cell-cycling_DCs\|Sigmoid / Region, Cell class and subclass	B3GNT5 EMILIN2 GRM1 FAM111B PKMYT1 CD14	6.57e-06	199	102	6	bd6f8c0f79e9a94cc0f8c6105d38851463de821c
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA1 EMILIN2 GPRIN3 RYR1 CD14 TLR1	6.57e-06	199	102	6	f34c15df58fbdc6c90e30800e26fabbf828ad10b
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA1 EMILIN2 GPRIN3 RYR1 CD14 TLR1	6.57e-06	199	102	6	5ceeed92f831d068ff4bb3994f420002338330e7
ToppCell	Sigmoid-(5)_Dendritic_cell-(52)_cycling_DCs\|Sigmoid / shred on region, Cell_type, and subtype	B3GNT5 EMILIN2 GRM1 FAM111B PKMYT1 CD14	6.57e-06	199	102	6	8ee78a39729633bcbb3ab17e1dfaca33f38db569
ToppCell	mild-HLA-DR+_CD83+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	EMILIN2 MYOF JUP ARHGEF40 CD14 IFI44L	6.76e-06	200	102	6	934c2efc780318c66d667ca75be0de350361d351
ToppCell	mild-CD163+_Monocytes_(Sample_ID1_d7)\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ABCA1 EMILIN2 MYOF JUP CD14 IFI44L	6.76e-06	200	102	6	82126e25bfd8fba78dc1348fa5ad6a576289a139
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	GPRIN3 CNKSR2 RYR1 CACNA1H TTC22	1.97e-05	143	102	5	5fb5a4ea93e5cce55d427e3b4a50a979504fad3c
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	EMILIN2 GRM1 IGFBP3 MYPN ARHGEF6	2.55e-05	151	102	5	090b067873740c282865e2d02cf47d5cb3dd7607
ToppCell	droplet-Marrow-nan-21m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 IP6K3 MYOF RASA4 TLR1	4.02e-05	166	102	5	91eeb48680dd07ae4115afacdc0a8f6fa18885e5
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D231\|Adult / Lineage, Cell type, age group and donor	VWF FAM111B IGFBP3 PLPP4 PLCB4	4.25e-05	168	102	5	aca34c51758c65925ad24110294a72b2dea6db72
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA1 ABHD6 CD14 RASA4 TLR1	5.16e-05	175	102	5	d983e80eeb11f341c564ea684e2b0b585a90ae58
ToppCell	Endothelial-A-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	VWF SAMD12 IGFBP3 PLPP4 EGFL8	5.60e-05	178	102	5	2f2602b9305d55f25afa9861dd6c6347ae179337
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GPRIN3 TRIM43 RYR3 TRIM43B IGFBP3	5.90e-05	180	102	5	a499548391e6833b78f6e920f8e32a755814a9da
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	VWF IP6K3 DSP EGFL8	6.23e-05	93	102	4	4eca07c288fe15531a685522c61746671c1c87fb
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	VWF IP6K3 DSP EGFL8	6.23e-05	93	102	4	312291db0fab96952017f9faf2057c28f3719556
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	VWF IP6K3 DSP EGFL8	6.23e-05	93	102	4	8f65381291fc92b56bf0fc2caac013a54560737b
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	VWF ANKRD37 ABHD6 PLCB4 IFI44L	6.38e-05	183	102	5	c1297d8eddfc7132e84ceef14f01b6281f9d0f6a
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	IP6K3 DSP IFI44L EGFL8	6.76e-05	95	102	4	53dde5363ea1d64386234e5bd4fbb28c057f2f21
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	IP6K3 DSP IFI44L EGFL8	6.76e-05	95	102	4	ef0b7289b348617a76b4643479adc7e9701c0094
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)--\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	IP6K3 DSP IFI44L EGFL8	6.76e-05	95	102	4	8b4d6b25ce28811a76ea11713d881117e495ef5e
ToppCell	COPD-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	DSP SAMD12 CCNO JUP IGFBP3	6.89e-05	186	102	5	d75fe7640a4b2c450c9759a1b3c3ef2a087f0092
ToppCell	Adult-Endothelial-endothelial_cell_of_artery\|Adult / Lineage, Cell type, age group and donor	VWF RYR3 IGFBP3 PLPP4 PLCB4	6.89e-05	186	102	5	2d1c4ea2e401db89971582ee54618a8b0c81b8ac
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EML6 SAMD12 PRKCA PLPP4 ATP6V0D2	7.07e-05	187	102	5	2d17408b3b5f09d135084fd7ccce98e6b5ca632b
ToppCell	Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA1 GPRIN3 RYR1 CD14 IFI44L	7.25e-05	188	102	5	3be2d50148daa4eddddc2c7f269f45c97f7e4931
ToppCell	IPF-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	SAMD12 ERI1 STAM MYOF ZNF282	7.43e-05	189	102	5	7a260485c2a7c743c14d048e5e480ae0a9b8e32c
ToppCell	facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSP GRM1 RYR3 MYPN CACNA1H	7.43e-05	189	102	5	e758b264c0a47127e33e66c395cf5a3224c7305b
ToppCell	facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSP GRM1 RYR3 MYPN CACNA1H	7.43e-05	189	102	5	b98f60875b1a12b2ec9dc91889298ae57f98602f
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF SAMD12 IGFBP3 PLCB4 EGFL8	7.62e-05	190	102	5	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SAMD12 GPRIN3 PRKCA PLPP4 ATP6V0D2	7.62e-05	190	102	5	b3bccf4dd95e986db3cee324a6737f5fcc22e8e5
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DSP OAT RYR1 PKMYT1 JUP	7.81e-05	191	102	5	0f9443da0f73d07456142fae08b2dc92a5b7b592
ToppCell	5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF IGFBP3 PLCB4 IFI44L EGFL8	7.81e-05	191	102	5	adb2e3efcad02889d8229325080da5e7830fd3ae
ToppCell	COPD-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	VWF SAMD12 MYOF IGFBP3 IFI44L	7.81e-05	191	102	5	ef16ad1c1cd2c0c0377957398c98775b62a81754
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EMILIN2 GPRIN3 RYR1 CD14 TLR1	8.20e-05	193	102	5	bd08555f02db8bc903caacae57e80bb91e2556ce
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EMILIN2 GPRIN3 RYR1 CD14 TLR1	8.20e-05	193	102	5	374d0526a071e973c3f43b4564f78f6933bb67ed
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EMILIN2 GPRIN3 RYR1 CD14 TLR1	8.40e-05	194	102	5	96f16bcd393a0d3f8df479b172b5360ae5a1e663
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-AT2-2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	VWF FAM111B ZBTB5 MTO1 SMCR8	8.40e-05	194	102	5	5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EMILIN2 GPRIN3 RYR1 CD14 TLR1	8.61e-05	195	102	5	91a3c439f10c03c5d51d904f512b6a08040edc76
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA1 EMILIN2 RYR1 CD14 TLR1	8.61e-05	195	102	5	42bfdff88da1d07828c0ad65d412fb1752f0cee4
ToppCell	Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	B3GNT5 GPRIN3 RYR1 CD14 TLR1	8.61e-05	195	102	5	312d9625655b38f1a7c2bf8f8bb7b667ebdf9617
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_4\|COVID-19_Mild / Disease condition and Cell class	ABCA1 JUP CD14 CSNK1A1 IFI44L	8.82e-05	196	102	5	3729d1444c65cad640377894decc64129bc3fd5b
ToppCell	severe-T/NK_proliferative\|severe / disease stage, cell group and cell class	SMC4 ERI1 FAM111B PKMYT1 CCT5	8.82e-05	196	102	5	89f005216770dbb84378f5d1f20ca11b0ce40faa
ToppCell	5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VWF IGFBP3 PLCB4 IFI44L EGFL8	9.03e-05	197	102	5	61b1b10a017cbeb17f8529fcae66cba77ee2f115
ToppCell	COVID-19-Epithelial-Club,_Basal_cells\|Epithelial / Condition, Lineage and Cell class	SAMD12 CCNO OAT RYR1 IGFBP3	9.03e-05	197	102	5	78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA1 GPRIN3 RYR1 CD14 TLR1	9.03e-05	197	102	5	10190b877bf46ba2163d203df9dd3b498c66e52f
ToppCell	severe-T/NK_proliferative\|World / disease stage, cell group and cell class	SMC4 ERI1 FAM111B PKMYT1 CCT5	9.03e-05	197	102	5	6b7b068b103fd4f6ceda8e01f4dd39eefc3b3633
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	B3GNT5 RYR1 PKMYT1 CD14 TLR1	9.03e-05	197	102	5	0a404b4494a2246d5a92299235056f0fda4d2b48
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABCA1 EMILIN2 JUP CD14 IFI44L	9.03e-05	197	102	5	383d598ce3f8f5fc98bef3300e4cf7b6992aec9c
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ABCA1 EMILIN2 JUP CD14 IFI44L	9.03e-05	197	102	5	3cc4e56a77f96a43f9b5a24cf1b9524c927ef795
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DSP OAT MYOF JUP IGFBP3	9.25e-05	198	102	5	9718f4c013c347f1b3c785ae232dd2fb6c1fe298
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	B3GNT5 EMILIN2 GPRIN3 IFI44L ATP6V0D2	9.25e-05	198	102	5	e125eb8aa57c172e5518874da1bd25998292f5e2
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)-D231\|Adult / Lineage, Cell type, age group and donor	ABCA1 B3GNT5 EMILIN2 GPRIN3 CD14	9.25e-05	198	102	5	79a415e19cedde13a88f5043d71557363f102322
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DSP OAT MYOF JUP IGFBP3	9.25e-05	198	102	5	89ec1e760a193441092571475cc66a3b425f232e
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	B3GNT5 EMILIN2 GPRIN3 IFI44L ATP6V0D2	9.25e-05	198	102	5	0baeb8e2c199ff10bb5c829c523546af3c9227c1
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	EMILIN2 JUP ARHGEF40 CD14 IFI44L	9.25e-05	198	102	5	06201b34d3e38f22c93b759511f7b376504bac06
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DSP OAT MYOF JUP IGFBP3	9.25e-05	198	102	5	3cc9e671f596ef0829684018e4257571fefb6267
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	EMILIN2 JUP ARHGEF40 CD14 IFI44L	9.25e-05	198	102	5	1ca91559fef231896e16180f5e050155c38f7cfa
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	SMC4 TRIM68 AKIP1 FAM111B PKMYT1	9.47e-05	199	102	5	3d876f172487425b37b2f658dae59e0f293ee76e
ToppCell	21-Trachea-Epithelial\|Trachea / Age, Tissue, Lineage and Cell class	B3GNT5 DSP ANKRD37 CCNO IGFBP3	9.47e-05	199	102	5	8eb8b086c38960200578a9fe8853ca6e894ddee4
ToppCell	suprabasal_cell\|World / shred by cell class for turbinate	DSP OAT MYOF JUP IGFBP3	9.47e-05	199	102	5	bfab5380ef074d14f0b5ed10851ad5c898eb9a58
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EMILIN2 GPRIN3 RYR1 CD14 TLR1	9.47e-05	199	102	5	744b63fba33b176ab7dde11646ccb313665505f7
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Macrophages\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA1 B3GNT5 EMILIN2 CD14 TLR1	9.47e-05	199	102	5	9df2c79904dacf029ec9df1f1cde72d871189a82
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA1 EMILIN2 RYR1 CD14 TLR1	9.47e-05	199	102	5	9545ac59c8d75f5747dff86cb511a149dc103b31
ToppCell	Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	VWF IGFBP3 PUS1 PLCB4 IFI44L	9.47e-05	199	102	5	bd43a84e84d8acb8e1008b98a235cc5bd5f43586
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TCF3 SMC4 FAM111B PKMYT1 JUP	9.47e-05	199	102	5	ea75804c34989c99aab542e6d72617ed144819b6
ToppCell	10x5'v1-week_12-13-Lymphocytic_B\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TCF3 SMC4 FAM111B PKMYT1 JUP	9.47e-05	199	102	5	713dfd8552635645db5e0b5721c64e5c9b4aa06c
ToppCell	mild_COVID-19_(asymptomatic)-Classical_Monocyte\|World / disease group, cell group and cell class (v2)	EMILIN2 JUP CD14 TLR1 IFI44L	9.47e-05	199	102	5	727122b6f4ca265d2826c9271b10a4215a9d45a3
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DSP OAT RYR1 MYOF JUP	9.47e-05	199	102	5	ba284f984909504221900bca5ea12ada5b2ffd9f
ToppCell	critical-Lymphoid-NKT-proliferating\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DSP SMC4 FAM111B PKMYT1 MYOF	9.47e-05	199	102	5	9284956d852e434a91be892e88e06a7c71f8c583
ToppCell	Parenchyma_Control_(B.)-Immune-TX-TRAM-2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	B3GNT5 GPRIN3 ERI1 DNAJA4 IFI44L	9.69e-05	200	102	5	7c56935446f10d202eafa1f9ee7cb0aae4c2607e
ToppCell	Tracheal-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA1 EMILIN2 GPRIN3 CD14 TLR1	9.69e-05	200	102	5	ad7ae5106141669b353800fece833b3cd5bdccee
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EMILIN2 GPRIN3 RYR1 CD14 TLR1	9.69e-05	200	102	5	f3dc07a7cc8cf041da8fe610d21af595818cf2d8
ToppCell	Sigmoid-Macrophage-Macrophage\|Sigmoid / Region, Cell class and subclass	ABCA1 B3GNT5 EMILIN2 CD14 ATP6V0D2	9.69e-05	200	102	5	9ee3a799de7bade1bfe94b6827461633f02bc1dc
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	B3GNT5 EMILIN2 GPRIN3 IFI44L ATP6V0D2	9.69e-05	200	102	5	a443e475e7a10c26a6173d1af961de6219e0e567
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	DSP TRIM68 MYOF PALS1 CSNK1A1L	9.69e-05	200	102	5	eac33be484dc443794e66e473f03e98406c2983e
ToppCell	Sigmoid-Macrophage\|Sigmoid / Region, Cell class and subclass	ABCA1 B3GNT5 EMILIN2 MYOF CD14	9.69e-05	200	102	5	b07ac0ff3b8530e99094678fed80f35949cafac8
ToppCell	Sigmoid-(6)_Macrophage-(60)_Macrophage\|Sigmoid / shred on region, Cell_type, and subtype	ABCA1 B3GNT5 EMILIN2 CD14 ATP6V0D2	9.69e-05	200	102	5	ad84a83a5a1893f7b053d39eddeca851463a8ff0
ToppCell	Sigmoid-(6)_Macrophage\|Sigmoid / shred on region, Cell_type, and subtype	ABCA1 B3GNT5 EMILIN2 MYOF CD14	9.69e-05	200	102	5	9e10cca4429de2c4c8c3c6cf2c9e28637a095be9
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	B3GNT5 EMILIN2 GPRIN3 IFI44L ATP6V0D2	9.69e-05	200	102	5	ed785a6d08ca2b350dc3307b587eadfb2886d1f9
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DRD2 EMILIN2 GRM1 IGFBP3	1.07e-04	107	102	4	fc07dd90f280191bd643398eac5c8273651d0925
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GPRIN3 RYR1 RYR3 CACNA1H	2.08e-04	127	102	4	fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GRM1 IGFBP3 MYPN ARHGEF6	2.21e-04	129	102	4	6bc85761dea1f97c19bb379a99e4daf85d53201e
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DRD2 EMILIN2 GRM1 IGFBP3	2.21e-04	129	102	4	f83187c0bb06528127b8d2d56674ab1946846951
Drug	Ryanodine	STAR RYR1 RYR3	1.51e-05	12	95	3	ctd:D012433
Drug	5'-adenylyl (beta,gamma-methylene)diphosphonate	RYR1 RYR3	1.72e-05	2	95	2	ctd:C005147
Drug	spinosyn A	ABHD6 FARP2	1.72e-05	2	95	2	CID000115003
Drug	Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A	TCF3 CCNO GRM1 CDKL1 MYOF TLR1 WIPI2	1.83e-05	196	95	7	2762_UP
Drug	Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A	TCF3 ABCA1 DRD2 RYR1 DNAJA4 PHF3 PRKCA	1.90e-05	197	95	7	2887_DN
Drug	NP-EGTA	RYR1 RYR3 PRKCA	2.48e-05	14	95	3	CID000183793
Drug	Dantrolene-13C3	GRM1 RYR1 RYR3 PRKCA CACNA1H DMD	3.28e-05	145	95	6	CID000002951
Drug	DB04210	MAGEA2 MAGEA6 TLR1	3.79e-05	16	95	3	CID005287853
Drug	AC1NUZ8M	GRM1 STAR RYR1 RYR3 CACNA1H	4.20e-05	92	95	5	CID000073211
Drug	kazinol B	RYR1 RYR3 PRKCA	4.59e-05	17	95	3	CID000480869
Drug	cis-diammineplatinum(II	RYR1 RYR3	5.15e-05	3	95	2	CID000159790
Drug	2-hydroxyheptanoic acid	RYR1 RYR3	5.15e-05	3	95	2	CID002750949
Drug	8N3-cADPR	RYR1 RYR3	5.15e-05	3	95	2	CID000127713
Drug	aminodantrolene	RYR1 RYR3	5.15e-05	3	95	2	CID009570289
Drug	NSC700089	OAT PPP4C	5.15e-05	3	95	2	CID000395475
Drug	2-hydroxycarbazole	RYR1 RYR3	5.15e-05	3	95	2	CID000093551
Drug	1,1'-diheptyl-4,4'-bipyridinium	RYR1 RYR3	5.15e-05	3	95	2	CID000080262
Drug	flubendiamide	RYR1 RYR3	5.15e-05	3	95	2	CID011193251
Drug	inositol pentaphosphate	IP6K3 IP6K2	5.15e-05	3	95	2	ctd:C013571
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR1 RYR3	5.15e-05	3	95	2	CID005748312
Drug	lidocaine	STAM RYR1 RYR3 PPP4C PRKCA DMD	5.69e-05	160	95	6	CID000003676
Drug	pioglitazone	ABCA1 VWF DSP OAT STAR RYR1 RYR3 FASN	6.69e-05	326	95	8	CID000004829
Disease	Epidermolysis bullosa, lethal acantholytic	DSP JUP	9.83e-06	2	93	2	C1864826
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR3	2.94e-05	3	93	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR3	2.94e-05	3	93	2	DOID:8545 (implicated_via_orthology)
Disease	Cardiomyopathies	DSP NDUFS2 JUP MYPN DMD	5.85e-05	130	93	5	C0878544
Disease	Mental Retardation, X-Linked 1	CNKSR2 DMD ARHGEF6	1.41e-04	32	93	3	C2931498
Disease	phosphate measurement	IP6K3 RYR3	2.04e-04	7	93	2	EFO_0010968
Disease	Arrhythmogenic right ventricular cardiomyopathy	DSP JUP	2.04e-04	7	93	2	cv:C0349788
Disease	syndromic X-linked intellectual disability Najm type (implicated_via_orthology)	CSNK1A1L CSNK1A1	2.04e-04	7	93	2	DOID:0060807 (implicated_via_orthology)
Disease	dilated cardiomyopathy (is_implicated_in)	DSP PRKCA DMD	3.41e-04	43	93	3	DOID:12930 (is_implicated_in)
Disease	alcohol use disorder (implicated_via_orthology)	DRD2 NDUFS2 RYR1 RYR3 PRKCA	3.89e-04	195	93	5	DOID:1574 (implicated_via_orthology)
Disease	nicotine dependence (implicated_via_orthology)	DRD2 PLCB4	6.35e-04	12	93	2	DOID:0050742 (implicated_via_orthology)
Disease	Hypertrophic Cardiomyopathy	DSP FASN MYPN	7.84e-04	57	93	3	C0007194
Disease	Colorectal Carcinoma	TCF3 ABCA1 CNKSR2 STAM GRM1 CSNK1A1L IGFBP3 DMD	1.70e-03	702	93	8	C0009402
Disease	Attention Deficit Disorder	DRD2 GRM1	2.18e-03	22	93	2	C0041671
Disease	Minimal Brain Dysfunction	DRD2 GRM1	2.18e-03	22	93	2	C1321905
Disease	proprotein convertase subtilisin/kexin type 9 measurement	ABHD6 CNKSR2	2.18e-03	22	93	2	EFO_0009312
Disease	aspartate aminotransferase measurement	ABCA1 NSD1 GPRIN3 ERI1 STAM CDKL1 CD14 MYPN PRKCA	2.21e-03	904	93	9	EFO_0004736
Disease	Attention deficit hyperactivity disorder	DRD2 GRM1	2.59e-03	24	93	2	C1263846
Disease	trans fatty acid measurement, trans/trans-18:2 fatty acid measurement	TRIM49 RYR3	2.59e-03	24	93	2	EFO_0006821, EFO_0006826
Disease	suicidal ideation, suicide behaviour	DRD2 EXD3	2.59e-03	24	93	2	EFO_0004320, EFO_0007623

Protein segments in the cluster

Peptide	Gene	Start	Entry
KNLHLVCVDMPGHEG	ABHD6	96	Q9BV23
LEKLGMDYDGRPHCG	ERI1	281	Q8IV48
QLGLHPNPECDREKM	LINC01590	26	Q5TEZ4
PHDLVLGVDGRTCME	EGFL8	171	Q99944
ERELEGPGLLCMAGH	ARHGEF40	471	Q8TER5
ENQHKVGGCLLSLMP	ARHGEF6	311	Q15052
VIRECGGKMHLREGE	COPS2	236	P61201
GDHPEAALEDCMGKL	CCNO	306	P22674
PHFCLGRGLIDMVKN	ABCA1	1811	O95477
KGCMGVLAREAPHLE	AKIP1	46	Q9NQ31
IKHGDLRCVRDEGMP	DNAJA4	296	Q8WW22
LMANRGDHCRKLVEP	DMD	1741	P11532
VCGGKGRNHDFLMEI	ATG2B	1596	Q96BY7
MLLLDCNPEVDGLKH	ANKRD37	1	Q7Z713
LCHEVKLGMQGPGQL	RASA4	276	O43374
FHLECLGLTEMPRGK	NSD1	1566	Q96L73
LCHEVKLGMQGPGQL	RASA4B	276	C9J798
GDRECSGMKLLGIHE	MINDY3	236	Q9H8M7
MPLEQRSQHCKPEEG	MAGEA2	1	P43356
MPLEQRSQHCKPEEG	MAGEA3	1	P43357
MPLEQRSQHCKPEEG	MAGEA6	1	P43360
MPLEQRSQHCKPEEG	MAGEA11	111	P43364
MPLEQRSQHCKPEEG	MAGEA12	1	P43365
HGKCPLLVRGKGEME	FER1L6-AS1	11	Q8NA97
PCVLDLKMGTRQHGD	IP6K2	216	Q9UHH9
KGHLMREVDALDGLC	MTO1	86	Q9Y2Z2
MRGHCHQPDMEGLEA	FLYWCH1	326	Q4VC44
LHADCEKEMLDGGVP	FAM182A	31	Q5T1J6
GAGLCMDDIPHILKG	IFI44L	271	Q53G44
DIKPDNFLMGTGRHC	CSNK1A1L	136	Q8N752
MNELENKAEPGTHLC	OSTM1	241	Q86WC4
PCVLDLKMGTRQHGD	IP6K3	211	Q96PC2
EGCTGALHILARDPM	JUP	561	P14923
MHCTGDPDLVSEGRK	PLPP4	126	Q5VZY2
LSGEMVRKCDPHIGL	NDUFS2	101	O75306
KHREMAVDCPGDLGT	PALS1	31	Q8N3R9
MGLCANKIGIVPQDH	B3GNT5	286	Q9BYG0
GLGERGLMAALCPHK	CD14	206	P08571
HGILCDDMGLGKTLQ	BTAF1	1286	O14981
ALGLLKGCLHMDPTQ	CDKL1	261	Q00532
HCEGRMTLKNLPLAD	DSP	681	P15924
KLGHELMLCAPDDQE	HAUS7	101	Q99871
MEGDRGDIVNCLEPH	DCAF8L1	476	A6NGE4
VGNIVKFLGMHPCER	COPG1	801	Q9Y678
RERDKPMLILQGHCE	EML6	311	Q6ZMW3
DICLLNIQGKPHGME	EMILIN2	551	Q9BXX0
LRAPLKGNCTHPEDM	DRD2	236	P14416
TIDGHINLGMPLKCL	FAM111B	136	Q6SJ93
MCRLLGIVPEANDGH	ENPP7	391	Q6UWV6
QHTCKEDGRLAGMTP	GPRIN3	431	Q6ZVF9
VRMHVGDGKLPCRSN	GRM1	856	Q13255
AGGAGMDCEEPRHKR	FARP2	516	O94887
RGQCIKEAHLPPGAM	FASN	606	P49327
DNGMQKCSHIPGRRE	CACNA1H	296	O95180
DLLGRCAPEMHLIQA	RYR1	2431	P21817
CAPEMHLIQAGKGEA	RYR1	2436	P21817
GTRMDLGECLKVHDL	LUC7L2	51	Q9Y383
GPCRREMEDTLNHLK	IGFBP3	211	P17936
CVLMLLEHGADRNIP	POTED	221	Q86YR6
MGCDGGTIPKRHELV	RTF2	1	Q9BY42
MCHKPDVELLQDLGD	TRIM43	236	Q96BQ3
MCHKPDVELLQAFGD	TRIM49	236	P0CI25
GEDQEPIITHGKAMC	PLCB4	366	Q15147
CGIMKRLAANFHPDG	TBC1D25	356	Q3MII6
NVPSLCGMDHTEKRG	PRKCA	146	P17252
KRQTAEDCPRMGEHQ	PRAMEF14	131	Q5SWL7
VRSGCIPENHGEDMR	PUS1	121	Q9Y606
DIKPDNFLMGIGRHC	CSNK1A1	136	P48729
HGGMLPRKITGLCQE	MRPS18A	96	Q9NVS2
EECVKMAHRAGLLPN	MRPS18A	116	Q9NVS2
QVKEMNPALGIDCLH	CCT5	481	P48643
MAVEALHCGLNPRGI	SAMD12	1	Q8N8I0
KRQTAEDCPRMGEHQ	PRAMEF1	131	O95521
PQEGGECALMKQHRL	WIPI2	361	Q9Y4P8
CCRDGGTGHIPLKEM	SPRYD7	11	Q5W111
CDDDIMLTIKPGEHG	OAT	306	P04181
LKGHDLCPGEMEHIQ	SMCR8	261	Q8TEV9
LPNLEKEGMQICLHE	TLR1	656	Q15399
LPGCDGLVMDEHLVA	TDGF1	146	P13385
EKGNLPCEDLRGHMV	CNKSR2	366	Q8WXI2
LDGQPCKIRLHMGDL	C11orf42	116	Q8N5U0
QCENPEVGLGEKEHM	ZBTB5	311	O15062
RLHPGMGLKGDLCER	TRIM68	86	Q6AZZ1
MGLKGDLCERHGEKL	TRIM68	91	Q6AZZ1
VRICMDEDGNEKRPG	VWF	1876	P04275
ELGRMCQLHLNSEKP	TCF3	571	P15923
ILEVACNMELPHGGE	PKMYT1	296	Q99640
EQKGVIRAEHGPTCM	STAR	211	P49675
LGRCAPEMHLIQTGK	RYR3	2296	Q15413
NGEELHGGKRVMECL	VPS35	686	Q96QK1
MCHKPDVELLQAFGD	TRIM49C	236	P0CI26
DSCRNGEKHMLPGLS	PHF3	1671	Q92576
ARCHEMKPNLGAIAE	SMC4	1081	Q9NTJ3
CHQMGPLIDEKLEDI	STAM	336	Q92783
FLHGDLRSMKVGCDP	TRIM51G	301	A0A3B3IT33
MCHKPDVELLQAFGD	TRIM49D1	236	C9J1S8
MCHKPEVELLQDLGD	TRIM43B	236	A6NCK2
MCHKPDVELLQAFGD	TRIM49B	236	A6NDI0
DRKQEVPHDGPMCDL	PPP4C	181	P60510
GLGGMPDRNHLACAK	TTC22	356	Q5TAA0
LPGCDGLVMDEHLVA	TDGF1P3	146	P51864
VCHQEPALRGEMAEG	ZNF282	36	Q9UDV7
LGKCHPLGRFTEMEA	ATP6V0D2	126	Q8N8Y2
GVEHMECEIKLEGPV	KMT2D	1656	O14686
CPALAHVEKQILGGM	EXD3	476	Q8N9H8
HPVMNGDKACGDVLV	MYOF	1251	Q9NZM1
LQAPGDMVAHEGRLC	MYPN	1076	Q86TC9